The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...

A collection of common and new medications is showing good results against the constellation of symptoms that individualize ...

Treatment involves addressing ... Folate-deficient megaloblastic anemia due to dietary insufficiency or antiepileptic drugs: 5 mg/day for 4 months Malabsorption: Up to 15 mg/day for 4 months Chronic ...

While anemia impacts nearly a quarter of the world's population ... marked by an inability to utilize stored iron due to ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

When the spleen enlarges to handle excess immune cells and inflammation, it can lead to discomfort, anemia, and a weakened immune ... company developing a pipeline of treatments and potential cures ...

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

As the leading chronic hematological issue for patients undergoing oncology treatments, chemotherapy-induced anemia continues to be a primary concern due to its impact on treatment efficacy and ...